SCHEMBL20047021

SCHEMBL20047021

Cc1cc(I)cc(C)c1S(=O)(=O)N1CCc2cc(-c3ccc(C#N)cc3)ccc2C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 4/20 0.45
AKR1C1 Q04828 2/20 0.45
DRD2 P14416 2/20 0.43
DRD3 P35462 2/20 0.43
HTR2A P28223 1/20 0.43
HTR2C P28335 1/20 0.43
HTR6 P50406 1/20 0.43
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
HSD17B3 P37058 1/20 0.38
USP30 Q70CQ3 1/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37
ESR2 Q92731 2/20 0.37
ESR1 P03372 1/20 0.37
LMNA P02545 1/20 0.36
CHRM5 P08912 1/20 0.36
CHRM1 P11229 1/20 0.36
HRH3 Q9Y5N1 2/20 0.36
OPRK1 P41145 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20047231 0.91 AKR1C3 (0.47) AKR1C3AKR1C1DRD2DRD3HTR2A
SCHEMBL20047031 0.91 AKR1C3 (0.48) AKR1C3AKR1C1MEN1KMT2AHSD17B3
SCHEMBL20047024 0.85 CHRM5 (0.41) AKR1C3AKR1C1MEN1KMT2AESR2
SCHEMBL20047027 0.84 PKM (0.51) AKR1C3AKR1C1MEN1KMT2AUSP30
SCHEMBL20047232 0.82 AKR1C3 (0.49) AKR1C3AKR1C1MEN1KMT2AHSD17B3
SCHEMBL20047020 0.82 MEN1 (0.40) AKR1C3AKR1C1MEN1KMT2AESR2
SCHEMBL20047019 0.81 MEN1 (0.40) AKR1C3AKR1C1MEN1KMT2AESR2
SCHEMBL20047032 0.81 KMT2A (0.47) AKR1C3AKR1C1MEN1KMT2AMAPT
SCHEMBL20047023 0.79 AKR1C3 (0.49) AKR1C3AKR1C1DRD3HTR2CMEN1
SCHEMBL20047029 0.79 CYP11B1 (0.50) CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017223514-A9 LXR INVERSE AGONISTS FOR TREATMENT OF CANCER SAINT LOUIS UNIVERSITY (US) 2018-04-12 WO disclosed